Diaceutics (LON:DXRX) Issues Earnings Results

Diaceutics (LON:DXRX) released its quarterly earnings data on Tuesday. The company reported GBX (2.02) (($0.03)) EPS for the quarter, Digital Look Earnings reports. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%.

Diaceutics Stock Down 3.7%

Shares of LON DXRX opened at GBX 130 ($1.73) on Wednesday. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39. Diaceutics has a 12-month low of GBX 103 ($1.37) and a 12-month high of GBX 151 ($2.01). The stock has a market cap of £109.71 million, a P/E ratio of -38.56 and a beta of 0.58. The business’s fifty day simple moving average is GBX 120.55 and its 200-day simple moving average is GBX 126.94.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.